Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 6:00 PM View:  | Wave Life Sciences Ltd. (WVE) | 12-Aug-24 | Grant | 16,115 | -- | -- | 100% 0 to 16.11K | |
| 17-Jan-24 5:31 PM View: | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 30,080 | $0.67 | $20,243.80 | (40%) 74.93K to 44.85K | |
| 17-Jan-24 5:31 PM View: | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 9,304 | $0.79 | $7,350.16 | (40%) 23.41K to 14.1K | |
| 12-Jan-24 5:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 17,257 | $0.85 | $14,739.20 | (40%) 43.65K to 26.39K | |
| 12-Jan-24 5:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 11,945 | $0.84 | $9,994.38 | (39%) 30.34K to 18.39K | |
| 01-Sep-23 7:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Sep-23 | Sale | 2,403 | $0.78 | $1,874.34 | (41%) 5.85K to 3.45K | |
| 27-Jun-23 9:15 PM View: | Adaptimmune Therapeutics plc (ADAP) | 27-Jun-23 | Sale | 2,333 | $0.92 | $2,146.36 | (40%) 5.85K to 3.52K | |
| 17-Jan-23 9:15 PM View: | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 10,057 | $1.86 | $18,685.90 | (43%) 23.41K to 13.35K | |
| 12-Jan-23 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 18,763 | $1.71 | $32,009.70 | (43%) 43.65K to 24.88K | |
| 12-Jan-23 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 13,042 | $1.75 | $22,781.80 | (43%) 30.34K to 17.3K | |
| 04-Jan-23 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 5,073 | $1.69 | $8,593.66 | (43%) 11.7K to 6.63K | |
| 01-Sep-22 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Sep-22 | Sale | 2,536 | $1.97 | $4,993.13 | (43%) 5.85K to 3.32K | |
| 27-Jun-22 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 27-Jun-22 | Sale | 2,562 | $1.63 | $4,176.06 | (44%) 5.85K to 3.29K | |
| 18-Jan-22 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 11,096 | $3.19 | $35,416.20 | (47%) 23.41K to 12.31K | (9%) |
| 13-Jan-22 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-22 | Market Sale | 3,046 | $3.54 | $10,795.30 | (48%) 6.4K to 3.36K | 2% |
| 13-Jan-22 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-22 | Market Sale | 14,362 | $3.56 | $51,081.30 | (47%) 30.34K to 15.98K | 2% |
| 05-Jan-22 9:04 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-22 | Market Sale | 5,532 | $4.06 | $22,483.20 | (47%) 11.7K to 6.17K | 6% |
| 01-Sep-21 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Sep-21 | Market Sale | 2,782 | $5.20 | $14,452.50 | (48%) 5.85K to 3.07K | < 1% |
| 28-Jun-21 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 28-Jun-21 | Market Sale | 2,794 | $4.37 | $12,209.80 | (48%) 5.85K to 3.06K | < 1% |
| 19-Jan-21 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 19-Jan-21 | Market Sale | 9,879 | $5.67 | $56,009.00 | (42%) 23.41K to 13.53K | (< 1%) |
| 12-Jan-21 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-21 | Market Sale | 2,707 | $6.15 | $16,654.00 | (42%) 6.4K to 3.69K | (1%) |
| 05-Jan-21 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-21 | Market Sale | 4,967 | $5.33 | $26,463.70 | (42%) 11.7K to 6.74K | (13%) |
| 02-Sep-20 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 01-Sep-20 | Market Sale | 2,776 | $8.51 | $23,637.40 | (47%) 5.85K to 3.08K | 38% |
| 04-Aug-20 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 03-Aug-20 | Market Sale | 2,788 | $9.25 | $25,789.00 | (48%) 5.85K to 3.06K | 42% |
| 15-Jan-20 8:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Jan-20 | Market Sale | 3,236 | $5.13 | $16,615.90 | (51%) 6.4K to 3.17K | (4%) |
| 07-Jan-20 8:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 06-Jan-20 | Market Sale | 5,900 | $1.20 | $7,080.00 | (50%) 11.7K to 5.8K | (343%) |
| 16-Jan-19 9:30 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Jan-19 | Market Sale | 3,084 | $5.37 | $16,559.20 | (48%) 6.4K to 3.32K | (< 1%) |
| 22-Mar-18 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 20-Mar-18 | Sale | 600,000 | $1.71 | $1,026,000.00 | (100%) 600.0K to 0 |